bremelanotide
-
S
My PT141 Arrived Today - Is 20 Units Considered Too Much?
Hi guys.. My pt141 arrived today with instructions to keep it refrigerated. I never tried it before in my life. Dosage of injection is 20 units. I assume 20 units is whats marked as '20' on the syringe, correct? If thats the case, is that considered too much for a 1st time user?- sileebo
- Thread
- bremelanotide erectile dysfunction libido pt141
- Replies: 6
- Forum: When TRT Is Not Enough (ED, Libido, & More)
-
C
A different dosing strategy with bremelanotide (PT-141) yields dramatically better results
TL;DR: It may be possible to improve results with bremelanotide by taking multiple daily micro-doses. Like many, I have experimented with bremelanotide at the recommended doses, which range from a few hundred micrograms up to a couple milligrams in one subcutaneous injection. And also like...- Cataceous
- Thread
- bremelanotide microdosing pt-141
- Replies: 68
- Forum: When TRT Is Not Enough (ED, Libido, & More)
-
S
Why so little info on Bremelanotide (PT-141-Vyleesi)?
There is an astonishing lack of talk on here about a drug which attempts to address something that we talk about all the time and have zero tools to fix - libido. Now that we have multiple phase three studies to review on Pubmed and an FDA approved product perhaps we need to start gathering...- stx359
- Thread
- bremelanotide pt-141 vyleesi
- Replies: 21
- Forum: When TRT Is Not Enough (ED, Libido, & More)
-
G
PT-141 officially FDA approved (for women)
FDA approves new treatment for hypoactive sexual desire disorder in premenopausal women PT-141 AKA Bremelanotide AKA Vyleesi approved. This should open up a whole new focus on the melanocortin system and allow for crowdsourcing the best dosing/timing. It seems something good is happening in...- Guided_by_Voices
- Thread
- bremelanotide pt-141
- Replies: 1
- Forum: HRT in Women
-
Bremelanotide (Vyleesi) for Female Sexual Disorder
Rekynda (bremelanotide), an investigational product, is thought to possess a novel mechanism of action, activating endogenous melanocortin pathways involved in sexual desire and response. The two Phase 3 studies for HSDD in pre-menopausal women consisted of double-blind placebo-controlled...- Nelson Vergel
- Thread
- Replies: 14
- Forum: HRT in Women
Beyond Testosterone Podcast
Share this page
Sponsors
